deltatrials
Completed NA INTERVENTIONAL 2-arm NCT01257711

A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer (SCAR)

A Prospective Randomised Study Comparing Billroth II With Roux-en-Y Reconstruction After Radical Distal Subtotal Gastrectomy for Gastric Cancer

Sponsor: Changi General Hospital

Updated 6 times since 2017 Last updated: Mar 5, 2021 Started: Oct 9, 2008 Primary completion: Jul 31, 2019 Completion: Feb 12, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Gastrectomy and Gastric Cancer and is currently completed. Changi General Hospital leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshotUnknown Status~Apr 2021 – ~Jul 2024 · 39 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Apr 2021 — Jul 2024 [monthly]

    Completed NA

    Status: Unknown StatusCompleted

  4. Jan 2021 — Apr 2021 [monthly]

    Unknown Status NA

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status NA

Show 1 earlier version
  1. Jan 2017 — Jun 2018 [monthly]

    Unknown Status NA

    First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Changi General Hospital
  • Chinese University of Hong Kong
  • National Healthcare Group, Singapore
  • Tan Tock Seng Hospital
Data source: National Healthcare Group, Singapore

For direct contact, visit the study record on ClinicalTrials.gov .